Fig. 6
From: Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians
Representative urinary microRNA marker for HCC. (A) The consistent upregulation of miR-93-5p in tissue with HBV-related HCC. (B) The consistent upregulation of miR-93-5p in plasma in HBV-related HCC. (C) The consistent upregulation of miR-93-5p in urine in HBV-related HCC. (D) Application of urinary miR-93-5p in the detection of HBV-related HCC. (E) Application of urinary miR-93-5p in the treatment monitoring of HBV-related HCC. (F) Application of urinary miR-93-5p in the prognosis of HBV-related HCC. (A–F) Reprinted from Zhou et al., 2022